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Abstract
Cyanide poisoning may occur following accidental fire-smoke inhalation or deliberate ingestion of salts.
Hydroxocobalamin represents a first-line life-saving antidote. Although hydroxocobalamin represents a first-line life-
saving antidote, it is still not promptly available in the emergency department. Sodium thiosulfate can be
administered in association with hydroxocobalamin whereas the delayed onset of clinical response makes sodium
thiosulfate less suitable for emergency use. We describe a case of cyanide intoxication of a 43-year-old man who
ingested an unknown amount of potassium cyanide, purchased via the Internet, in an attempted suicide. At
admission to the emergency department, the patient presented GCS 3 with severe lactic acidosis. Orotracheal
intubation, gastric lavage and oral activated charcoal were applied. Sodium thiosulfate was available in the
emergency department and 10 grams were infused over a 30 minute period. Hydroxocobalamin was prescribed by
the poison control centre and 5 grams were infused 2 hours after admission. Following sodium thiosulfate
administration the patient was arousable and lactate concentration improved. No adverse effects were noted.
Metabolic acidosis completely resolved 12 hours later. Cyanide concentration performed on blood samples collected
at admission confirmed high cyanide blood levels (15 mg/L). This report highlights as the first-line administration of
sodium thiosulfate, in rapid infusion, resulted effective and safe for cyanide poisoning. Our report suggests that
sodium thiosulfate should be considered when hydroxocobalamin is not promptly available in an emergency setting.
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Introduction
Cyanide is a potent and fast acting poison, available in gaseous
forms, poorly water-soluble salts and water-soluble potassium or
sodium cyanide salts [1-4]. Cyanide exposure may occur following
accidental enclosed fire-smoke inhalation or ingestion of salts.
Cyanide ingestion is mainly related to accidental events, deliberate
self-harm or attempted homicides [1-4]. The ingestion of a minimal
amount of potassium cyanide salts (200-300 mg) may cause death
within minutes [1,5]. Furthermore, cyanide intoxication remains a
challenging diagnosis since initial symptoms are not specific, and
laboratory confirmation is not usually available in an emergency
setting [3]. Treatment includes supportive and antidotal therapy.
Currently two antidotes have been proposed for empiric therapy in
cyanide poisoning: hydroxocobalamin and sodium thiosulfate.
Hydroxocobalamin, a precursor of vitamin B12, represents the first-
line antidote, owing to its efficacy, safety and scarcity of severe side
effects [3,4,6]. Sodium thiosulfate can be administered in association
with hydroxocobalamin whereas the delayed onset of clinical response
makes sodium thiosulfate less suitable for emergency use [4,6]. We
describe a laboratory confirmed case of severe cyanide intoxication
following ingestion of potassium salts, purchased on the Internet,
where the prompt administration of sodium thiosulfate improved
clinical outcome and lactic acidosis.
Case Report
A 43-year-old man (90 kg) was admitted at the Emergency
Department (ED) after sudden collapse at work. He had ingested 1
hour before an unknown amount of extra pure potassium cyanide,
purchased on the Internet, in an effort to commit suicide. The patient
had a history of depressed mood, treated with Paroxetine (40 mg/die),
Gabapentin (900 mg/die) and Sodium Valproate (600 mg/die). In
addition, he had attempted suicide five months before. At admission,
the patient was unresponsive, Glasgow Coma Scale (GCS) 3, with
blood pressure 125/70 mmHg and pulse rate 120 beats/min. Areflexic
bilateral mydriasis was present. Orotracheal Intubation (IOT) was
applied and 50 grams activated charcoal coupled with 30 grams
magnesium sulphate were administered after gastric lavage. Fluid
resuscitation was started and a bolus of 10 ml/kg crystalloids infused.
Arterial Blood Gas (ABG) revealed severe lactic acidosis (pH 7.24,
pCO2 26.6 mmHg, pO2 202 mmHg, HCO3 13.6 mmol/L, base excess
−15 mmol/L, serum lactate 18 mmol/L, FiO2 60%; Figure 1) and blood
gas performed on venous blood (collected from external jugular vein)
showed venous arterialization (SvO2 89.9%, FeO2 7.2%).
Electrocardiogram demonstrated ventricular conduction delay; brain
computed tomography scan and chest X-ray revealed no
abnormalities. Blood samples were collected to detect cyanide
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concentration. All other laboratory parameters were within the range
of normality.
Figure 1: pH levels, HCO3, base excess and serum lactate at ED
admission, 1 hour after the ingestion of potassium cyanide. Figure
shows as HCO3, base excess and serum lactate improved quickly
after ST administration. (ED: Emergency Department; ST: Sodium
Thiosulfate; H: Hydroxocobalamin).
Sodium thiosulfate was available in the ED and 10 grams were
infused in 30 minutes. Following sodium thiosulfate administration
the patient was arousable and lactate concentration (9.2 mmol/L), as
well as base excess (-9.4 mmol/L) and HCO3 (16.1 mmol/L) improved.
Hydroxocobalamin was prescribed and provided by poison control
centre and 5 grams subsequently infused 3 hours after ED admission.
The patient showed further improvement of acid base balance (pH
7.27, pCO2 54.7 mmHg, pO2 101 mmHg, HCO3 22.1 mmol/L, base
excess −1.4 mmol/L, serum lactate 2.3 mmol/L, FiO2 50%), SvO2
65.2% FeO2 31%, and was fully responsive to verbal stimuli and orders.
The patient was moved to intensive care unit; fluid therapy and
mechanical ventilation were performed (10 ml/kg crystalloids infused
and FiO2 50%); acid-base balance continually controlled. Metabolic
acidosis completely resolved 12 hours later (pH 7.39, pCO2 44.7
mmHg, pO2 164 mmHg, HCO3 26.7 mmol/L, serum lactate 1.2
mmol/L), no additional episodes of lactic acidosis were noted and IOT
was removed 24 hours from ED admission. Laboratory findings
showed cyanide serum concentrations of 15 mg/L at admission,
declined to 0.2 mg/L 24 hours later. The patient remained
neurologically intact and haemodynamically stable throughout the
hospital stay. Four days later, he was moved to the psychiatric
department and discharged asymptomatic 9 days later.
Discussion
Cyanide poisoning is a life-threatening condition. Its lethality is
related to the rapid onset of toxicity and lack of pathognomonic
symptoms [4]. Furthermore blood cyanide concentration should be
detected to confirm the poisoning, therefore delaying the diagnosis
[3,4]. The first line treatment is frequently based on clinical features
and circumstantial evidence [3,4].
Cyanide exerts its toxicity by binding to cytochrome c oxidase a3,
causing a cytotoxic hypoxia [2-4,7]. As a result the aerobic respiration
is paralyzed with a buildup of lactate in mitochondria and rapid
impairment of vital functions [2-4,7]. Clinical features include loss of
consciousness, respiratory abnormalities, cardiovascular dysfunction,
and severe hypotension progressing rapidly to cardio-respiratory
arrest [2,5-7]. In this frame, diagnosis of cyanide poisoning requires a
careful correlation of the patient medical history, physical
examination, and laboratory findings as severe lactate acidosis with
increased anion gap [6]. Treatment includes supportive treatment and
antidotal therapy [6].
Gastric lavage and cathartics aimed to remove any remaining
cyanide salts in the gastrointestinal tract should be started as soon as
possible. Although its usefulness may be questionable, the prompt
administration of activated charcoal dose may reduce potassium
cyanide absorption [8]; simultaneously, high flow oxygen should be
administered and metabolic acidosis treated with bicarbonate [2,5-7].
Currently several antidotes, with differing mechanisms of action,
are available [4,6,7,9]. Hydroxocobalamin is the first-line antidote in
case of cyanide exposure. Its action consists in chelating cyanide to
form cyanocobalamin, which is excreted in urine [4,6,9]. Moreover,
hydroxocobalamin does not interfere with tissue oxygenation,
improving the hemodynamic stability of the patients admitted in ED
in shock or with hypotension [9]. Sodium thiosulfate reduces cyanide
toxicity by converting cyanide into the nontoxic thiocyanate through
the action of the enzyme rhodanase [2,4]. Conflicting results on the
efficacy of sodium thiosulfate arise from studies conducted in animals
and the efficacy of sodium thiosulfate is based on case reports [4].
Indeed, although it has been shown that sodium thiosulfate infusion
accelerates the conversion of cyanide to thiocyanate by rhodanase
enzyme, the slow onset of such effect suggests that sodium thiosulfate
may have a preventive, more than a curative, function [4]. Thiosulfate
provides a delayed but lasting and reliable effect, therefore continuous
infusion associated with hydroxocobalamin is recommended
[4,6,9,10]. Currently, there are no clinical trials comparing the efficacy
of combining hydroxocobalamin and sodium thiosulfate versus the
administration of one of these treatments alone [10]. However the
rapid infusion of sodium thiosulfate immediately after
hydroxocobalamin could decrease the effectiveness of the treatment
due to the formation of thiosulfate-cobalamin unable to bind cyanide
[10]. In this case several factors contributed to a favourable outcome:
patient’s history and ABG findings allowed a rapid diagnosis, the high
body-weight of the patient and the possibility to administer both
sodium thiosulfate and hydroxocobalamin. Anyway, following sodium
thiosulfate administration both the neurological deficits and lactic
acidosis improved rapidly.In particular first administration of sodium
thiosulfate was able to rescue cyanide toxicity in presence of higher
blood cyanide levels than those reported in medical literature and no
adverse effects were noted [9]. A rapid schedule of infusion (less than
30 minutes) was tolerable and could have played a role in enhancing
the clinical response to sodium thiosulfate alone.
Conclusion
In conclusion, the efficacy of sodium thiosulfate is based on
individual case reports [9,10]. Currently, the first line administration
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of sodium thiosulfate is recommended in mild or moderate poisonings
[10]. This case highlights as sodium thiosulfate, in rapid infusion,
could be considered an early first-line efficacious treatment in cyanide
poisonings.
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